Biblio
Found 232 results
Author [ Keyword
Filters: Author is Martin, Eden R [Clear All Filters]
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
.
2011. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.. Nat Genet. 49(9):1373-1384.
.
2017. Transethnic genome-wide scan identifies novel Alzheimer's disease loci.. Alzheimers Dement. 13(7):727-738.
.
2017. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
.
2014. The ubiquilin 1 gene and Alzheimer's disease.. N Engl J Med. 352(26):2752-3;authorreply2752-3.
.
2005. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
.
2006. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
.
2004. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
.
2014. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
.
2011. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.. Hum Mol Genet. 12(24):3259-67.
.
2003. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.. JAMA Neurol. 72(2):209-16.
.
2015. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
.
2006. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
.
2004. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
.
2014. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
.
2011. Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
.
2004. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.. Am J Hum Genet. 84(1):35-43.
.
2009. Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.. PLoS Genet. 6(9):e1001130.
.
2010. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.. Hum Mol Genet. 12(24):3259-67.
.
2003. Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
.
2016. Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
.
2016. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.. JAMA Neurol. 72(2):209-16.
.
2015. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.. Neurobiol Aging. 27(8):1087-93.
.
2006. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
.
2004. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
.
2014.